We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GBDC:NASDAQGolub Capital BDC, Inc. Analysis

Data as of 2026-04-05 - not real-time

$12.70

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Golub Capital BDC trades at a forward P/E of 9.8, well below the industry average of 16.6, and its price‑to‑book ratio of 0.86 suggests a discount to net asset value. The stock yields an eye‑catching 11.8% dividend, but a payout ratio of 124% raises concerns about sustainability, especially given a high debt‑to‑equity ratio of 125 and cash reserves that cover less than 2% of total debt. Technically, the 20‑day SMA (12.38) sits just below the current price (12.70) while the 50‑day SMA (12.58) remains above it, and the MACD histogram is positive, indicating a modest bullish signal amid an overall bearish trend and decreasing volume. Volatility is elevated at roughly 24% over the past 30 days, and beta below 1 (0.72) points to lower market sensitivity but does not offset the company‑specific risks.
Recent earnings of $0.38 per share were in line with expectations, showing a slight decline from $0.39 a year ago, and the stock has recently tested its 52‑week low around $12.0, suggesting limited upside momentum. The combination of a high dividend yield, undervalued multiples, and a modest upside potential of 13% must be weighed against the heavy leverage, flat earnings growth, and questionable dividend coverage. Given the “Extreme Greed” market sentiment, investors should be cautious, focusing on the company’s ability to manage debt and sustain its dividend before committing capital.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near technical resistance at $12.87
  • Flat earnings and high payout ratio
  • Decreasing volume indicating waning short‑term interest

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued valuation multiples relative to peers
  • Potential upside of ~13% to target price
  • Strong operating margins providing cash flow cushion

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High leverage requiring ongoing debt management
  • Dividend yield attractive but sustainability uncertain
  • Sector exposure to middle‑market credit risk

Key Metrics & Analysis

Financial Health

Revenue Growth-6.20%
Profit Margin38.57%
P/E Ratio10.2
ROE8.34%
ROA4.70%
Debt/Equity124.81
P/B Ratio0.9
Op. Cash Flow$473.1M
Free Cash Flow$301.4M
Industry P/E16.6

Technical Analysis

TrendBearish
RSI55.1
Support$11.87
Resistance$12.87
MA 20$12.38
MA 50$12.58
MA 200$13.83
MACDBullish
VolumeDecreasing
Fear & Greed Index78.8

Valuation

Target Price$14.32
Upside/Downside12.76%
GradeUndervalued
TypeValue
Dividend Yield11.81%

Risk Assessment

Beta0.72
Volatility24.32%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.